TP53 and ependymoma: Higher TP53 scores were associated with significant survival risks (Table S4) within DMGs (HR = 6436, 95% CI = 2.67–1.55e7, p = 0.03) and ependymomas (HR = 2003, 95% CI = 9.9–4.05e5, p = 0.005).